TLRY stock forecast
Our latest prediction for Tilray, Inc.'s stock price was made on the Dec. 11, 2019 when the stock price was at 18.20$.
In the short term (2weeks), TLRY's stock price should underperform the market by -8.02%. During that period the price should oscillate between -11.64% and +9.12%.
In the medium term (3months), TLRY's stock price should underperform the market by -18.46%. During that period the price should oscillate between -38.47% and +18.60%.Get email alerts
About Tilray, Inc.
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
At the moment the company generates 136M USD in revenues.
On its last earning announcement, the company reported a loss of -1.47$ per share.
The book value per share is 0.38$
Three months stock forecastDec. 11, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|